Published today in Clinical Cancer Research, findings from a study led by investigators at the Vall d'Hebron Institute of Oncology (VHIO), which forms part of the Vall d'Hebron Campus, underscore the efficacy of analyzing ...
Dec 17, 2025
0
10
A blood test could help doctors decide which patients with colon cancer should receive anti-inflammatory medication along with chemotherapy after surgery, according to a study appearing in JAMA Oncology. Based on data from ...
Dec 15, 2025
0
12
People with operable diffuse pleural mesothelioma may benefit from immunotherapy before and after surgery, based on results of a clinical trial exploring the sequence of treatment and the role of surgery for this difficult ...
Sep 8, 2025
0
28
A Mayo Clinic study finds that a shortened, less intense course of radiation and chemotherapy after minimally invasive surgery for HPV-positive oropharyngeal squamous cell carcinoma (HPV+OPSCC) results in less toxicity, substantially ...
Sep 2, 2025
0
19
By sparking the immune system into action, radiation therapy makes certain tumors that resist immunotherapy susceptible to the treatment, leading to positive outcomes for patients, according to new research by investigators ...
Jul 22, 2025
0
42
Altum Sequencing, a start-up supported by the C3N-IA Science Park at Universidad Carlos III de Madrid (UC3M) and specialized in oncology, has developed a tool to monitor treatment response in patients with solid tumors from ...
Jun 19, 2025
0
34
Many men with aggressive prostate cancer can experience a high rate of recurrence despite treatment.
Jun 1, 2025
0
28
A review now published in the Journal of Experimental & Clinical Cancer Research offers a sweeping and authoritative synthesis of the use of liquid biopsy in gynecological oncology, placing this emerging tool at the forefront ...
May 9, 2025
0
20
Pembrolizumab (Keytruda), an anti-PD-1 antibody, cleared minimal residual disease and protected against recurrence in patients with DNA mismatch repair-deficient (dMMR) early-stage solid cancers who had detectable circulating ...
Apr 29, 2025
0
16
Mayo Clinic researchers have identified a potential new way to monitor the progression of high-grade gliomas, one of the most aggressive types of brain cancer. Their feasibility study suggests that a personalized blood test ...
Apr 24, 2025
0
9
